Compared to IDH-wt GBM, IDH-mut LGGs affect younger patients, have a significantly lower growth rate carrying a much better prognosis, and generally do not show contrast enhancement on T1-weighted brain MRI at initial diagnosis. The gene discussed is IDH2; the disease is glioblastoma.